July 22, 2014 / 6:20 PM / in 3 years

BUZZ-U.S. Stocks on the Move-Chipotle, Herbalife, Yingli Green Energy

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)

U.S. stocks rose on Tuesday as inflation data was seen keeping the Federal Reserve in an equities-friendly tone, while hopes rose for an easing of tensions in Ukraine. The Dow Jones industrial average was up 0.45 percent at 17,128.79, the S&P 500 was up 0.58 percent at 1,985.11 and the Nasdaq Composite was up 0.78 percent at 4,459.11.

** CHIPOTLE MEXICAN GRILL INC, $665.497, +12.81 pct

One of the top-performing U.S. restaurant operators on Monday reported a nearly 26 percent jump in quarterly profit after traffic to the burrito chain surged despite a menu price increase.

Deutsche Bank, UBS, Barclays and nine other brokerages raised their price targets on stock.

The stock was the top percentage gainer in morning trading on the new York Stock Exchange on Tuesday.

** HERBALIFE LTD, $64.1, +18.66 pct

Herbalife shares rallied on Tuesday in heavy volume, although they only recovered about half of Monday’s steep decline. The move came as Bill Ackman, chief executive of Pershing Square Capital Management and a vocal short against the company, hurled fresh accusations against the nutrition company on Tuesday, claiming its recruiting methods violate U.S. labor laws by employing drinks makers and babysitters without pay.

** SILICOM LTD, $29.76, -23.73 pct

The computer networking equipment maker’s second-quarter revenue fell 6 percent from first quarter due to “softer demand.”

The company said, “Challenges may remain with us for the short term.” The company’s shares fell to their lowest since April 2013. Needham also cut its rating on the stock to “hold” from “buy”.

** MCDONALD‘S CORP, $96.21, -1.37 pct

The fast-food chain reported a lower-than-expected quarterly profit as comparable sales in its struggling U.S. business fell for the third straight quarter and sales in Europe declined for the first time in four quarters.

** ON TRACK INNOVATIONS LTD, $2.3, +7.48 pct

The wireless payment system maker received a $6.2 million purchase order for near-field communication (NFC) readers from a U.S. channel partner.

The company said the NFC readers would be delivered over 18 months.

** HEALTHSTREAM INC, $26.21, +17.80 pct

The company, which provides Internet-based learning and research software to healthcare providers, reported second-quarter revenue of $42.5 million, higher than the analysts’ average estimate of $41 million.

HealthStream also narrowed its full-year revenue growth forecast to 26 percent-29 percent from 25 percent-29 percent.

** CARDTRONICS INC, $35.98, +11.19 pct

The ATM operator said it would acquire Welch ATM for $160 million. The merger will combine leading providers of ATM services to Walgreen Co, and adds Rite Aid Corp as a significant retail partner.

** ARM HOLDINGS PLC, $45.58, +7.07 pct

The seller of blueprints for chip designs posted a 9 percent rise in second-quarter profit as licensing of its processor technology compensated for a slowdown in high-end smartphone sales that decimated growth in royalties.


The Chinese solar company opened its third office in Latin America in Santiago, Chile.

The company already has deployed more than 25 megawatts of solar modules in Chile. In Latin America, Yingli also has offices in Brazil and Mexico. Yingli had sponsored the football World Cup in Brazil, and also powered the stadium at Maracana, where the final match was played.

** COCA-COLA CO, $41.12, -3.02 pct

The maker of Sprite, Minute Maid and Powerade reported lower-than-expected quarterly revenue as sales in North America, its biggest market, failed to show growth for the second straight quarter.

** HARLEY-DAVIDSON INC, $62.87, -6.28 pct

The motorcycle maker cut its full-year forecast for motorcycle shipments on Tuesday, citing weaker-than-expected U.S. retail sales and a delay in getting its newest bike into dealer showrooms.


The Chinese for-profit education provider said it expected first-quarter revenue of $412.0 million-$427.5 million, far below the analysts’ average estimate of $463.3 million. But the company reported fourth-quarter revenue above the consensus estimate.

** ALLEGHENY TECHNOLOGIES INC, $44.07, -3.02 pct

The metal processor posted a surprise second-quarter loss, hurt by costs related to its Rowley titanium sponge facility in Utah. The company reported a loss of 3 cents per share compared with analysts’ average expectation of a profit of 1 cent.

The stock is the only loser on the Dow Jones U.S. Iron and Steel index.

** GALENA BIOPHARMA INC, $2.91, +4.30 pct

The drug developer was granted U.S. rights for MonoSol Rx’s oral soluble film used to prevent nausea and vomiting induced by chemotherapy, radiotherapy or after surgery.

The agreement includes undisclosed upfront payment from Galena to the New Jersey-based company, as well as double-digit royalty payments from sales of the therapy, Zuplenz.

** POLARIS INDUSTRIES INC, $145.24, +9.06 pct

The snowmobile maker raised its full-year forecast after off-road vehicle sales increased 13 percent in the second quarter.

Polaris, one of the top percentage gainers on the NYSE, is not facing headwinds affecting rival Harley-Davidson Inc , which cut its full-year forecast for motorcycle shipments


JPMorgan raised its rating on the auto parts maker’s stock to “neutral” from “underweight”, citing strong North American auto sales. Seven of 10 brokerages covering the stock have a “buy” or higher rating, one rates it “hold” and two have “sell” ratings. The analysts’ median price target on the stock is $22, unchanged for the past 90 days.

** TG THERAPEUTICS INC, $8.49, -11.47 pct

The drug developer reported late on Monday a bigger-than-expected loss in the quarter ended June 30.

The larger loss was primarily due to a $6.4 million increase in non-cash compensation expense related to equity incentive grants. The company’s loss of 36 cents per share was bigger than Wall Street’s average estimate of 26 cents.

** CREDIT SUISSE GROUP AG, $28.57, -1.69 pct

The Swiss bank will quit commodities trading after chalking up its biggest loss since the financial crisis in 2008, the result of a 1.6 billion Swiss franc ($1.78 billion) fine from U.S. authorities for helping its clients evade taxes. ($1 = 0.9004 Swiss Francs)

** LEXMARK INTERNATIONAL INC, $48.75, +3.86 pct

The printer maker’s second-quarter profit and revenue beat the analysts’ average estimate.

Lexmark said it now expects full-year revenue to remain unchanged or fall up to 2 percent. It had earlier forecast a 2-4 percent decline. The company raised its full-year adjusted profit forecast to $3.95-$4.15 per share from $3.80-$4.00.

** ROCKWELL COLLINS INC, $77.69, -3.41 pct

The avionics maker reported third-quarter revenue of $1.26 billion, lower than the $1.30 billion analysts on average had expected, according to Thomson Reuters I/B/E/S.

Government systems sales fell 6 percent to $535 million, partly due to lower hardware deliveries.

** CYMABAY THERAPEUTICS INC, $5.45, -8.71 pct

The drug developer said it would offer 4 million shares at $5.50 each, representing 40 percent of the company’s outstanding shares as of April 30.

The offer price represents discount of about 8 percent to the stock’s Monday closing.


The regional bank reported a net income of $1.4 million, or 4 cents per share, in the second quarter ended June 30, compared with a loss of $803,000, or 10 cents per share, a year earlier. Net interest income increased 13 percent to $5.6 million.

** VALSPAR CORP, $79.12, +3.86 pct

Goldman Sachs said it expected the coating and paint maker to benefit from a recovery in the U.S. housing market and added it to ‘Americas Conviction List’. The brokerage also raised its rating on the stock to “buy” from “neutral.” Of the 15 brokerages covering Valspar, two have a “strong buy” rating, 5 have a “buy”, 7 have a “hold” and 1 a “sell.”

** APACHE CORP, $103.61, +5.12 pct

Activist investor Jana Partners LLC has built a stake worth more than $1 billion in Apache, the Wall Street Journal reported. (on.wsj.com/UkTOUB)

Jana Partners said it wants the company to drill exclusively on American soil and sell its international holdings. The investor wants Apache to free up cash flow by exiting two projects in Canada and Australia that aim to export natural gas.

** COMBIMATRIX CORP, $2.4, +6.67 pct

The molecular diagnostics company signed an agreement to join a network of directly managed preferred provider organizations maintained by Atlanta-based Stratose.

Patients pay less for care when they use the services of doctors, hospitals and pharmacies in preferred provider organization networks.

** CENTENE CORP, $80.06, +5.93 pct

The health insurer reported a 24 percent jump in quarterly profit, beating market estimates for the sixth straight quarter, as member signups surged 23 percent.

** MELA SCIENCES INC, $2.4699, -12.10 pct

The medical device maker offered a private placement of $27.3 million to fund clinical research and development. The company offered warrants to buy about 11.2 million shares at $2.45 per share, a discount of 12.8 percent to Monday’s close.

** KIMBERLY CLARK CORP, $109.69, -2.33 pct

The personal care and hygiene products maker lowered the high end of its full-year adjusted earnings forecast range. The company cut its forecast range to $6.00-$6.15 per share from $6.00-$6.20, citing a “difficult environment.”

The company’s quarterly profit missed the analysts’ average estimate by 1 cent, hurt by higher input costs and foreign currency exchange rates.

** BANCORPSOUTH INC, $21.55, -7.95 pct

The lender’s merger agreements with Ouachita Bancshares Corp and Central Community Corp were extended to June 30, 2015 to get regulatory approvals and satisfy closing conditions. Federal bank regulators identified concerns regarding the bank’s compliance programs, while the Consumer Financial Protection Bureau was conducting a review of the company’s fair lending practices. BancorpSouth’s net income rose to $30.9 million, or 32 cents per share, in the second quarter ended June 30, from $20.8 million, or 20 cents per share, a year earlier.

** TREX CO INC, $28.75, +6.21 pct

Stifel Nicolaus raised its rating on the plastic composite product maker’s stock to “buy” from “hold”, citing the company’s growing market share. Of the five analysts covering Trex, three have a “strong buy” rating, one has a “buy” rating and two have a “hold” rating, according to Thomson Reuters data. The median price target on Trex’s shares is $40.

** ROWAN COMPANIES PLC, $31.14, +0.35 pct

U.S.-based investment firm Blue Harbor Group LP reported a 6.5 percent stake in the offshore drilling company.

** PRETIUM RESOURCES INC, $7.35, -6.84 pct

The Canada-based gold miner priced an offering of 8.3 million shares at $7.25 each - 8.1 percent below Monday’s close of $7.89.

The offering represents 7.6 percent of Pretium’s total outstanding shares. Pretium said it would use proceeds from the offering to fund its Brucejack Project in British Columbia.

** COMCAST CORP, $54.79, +1.80 pct

The largest U.S. cable operator’s quarterly profit beat estimates as its high-speed Internet business added the most number of customers in six years and profitability improved at NBC Universal.

** DEL FRIJOL‘S RESTAURANT GROUP INC, $22.52, -10.74 pct

The company reported second-quarter revenue and profit below the analysts’ average expectation.

Del Frisco’s cut its 2014 profit forecast, citing delays in opening several restaurants and also lowered sales projections for Chicago Del Frisco’s Double Eagle, based on current sales, and for Palm Beach Del Frisco’s Grille, which has not yet received clearance to serve lunch, brunch or make use of patio seating.

** FBR & CO, $28.12, +11.15 pct

The investment bank said it would buy back up to 1 million shares at $28-$29 per share. The buyback represents 9.9 percent of the company’s total outstanding shares

** TRAVELERS COMPANIES INC, $91.845, -3.58 pct

The property and casualty insurer reported a steeper-than-expected fall in quarterly operating profit, hurt by bigger catastrophe losses and a slowing pace of premium rate increases.

Separately, a federal appeals court, on Tuesday, ordered Travelers to pay more than $500 million to satisfy asbestos-related claims stemming from the insurer’s coverage of insulation maker Johns-Manville Corp, a policyholder that spent six years in bankruptcy during the 1980s.

** CADENCE DESIGN SYSTEMS INC, $16.845, -3.74 pct

JPMorgan downgraded the electronics design software maker’s stock to “neutral” from “overweight”, as analysts expected hardware gross margin pressure throughout 2H14 to impact cash flow. On Monday, Cadence forecast third-quarter adjusted profit of 23-25 cents per share, below the analysts’ average estimate of 26 cents.

The company also forecast full-year adjusted profit of 90-98 cents per share, largely below the average estimate of 97 cents.

** OMNICOM GROUP INC, $72.05, +1.01 pct

The No.1 U.S. advertising company said it was sticking with its annual organic revenue growth target, showing little effect from its aborted $35 billion merger with France’s Publicis Groupe.

** UNITED TECHNOLOGIES CORP, $110.95, -1.80 pct

The Otis elevator maker said China orders at its Otis business were flat at the end of second quarter. Sales at Pratt & Whitney aerospace business were also down.

The company cut its 2014 profit forecast to $6.75-$6.85 per share, below the analysts’ average estimate of $6.86, according to Thomson Reuters I/B/E/S.

** CROCS INC, $16.62, +11.99 pct

The shoemaker said it would cut 183 jobs, close 75-100 retail stores and reduce direct investment in smaller markets to cut costs. The company also said it would explore strategic alternatives for non-core brands and eliminate non-core product development

Crocs also posted better-than-expected second-quarter profit and sales, and forecast that 2015 revenue would be hurt by store closures before revenue growth resumes in 2016 and beyond.

** FUELCELL ENERGY INC, $2.541, +14.98 pct

The fuel cell power plant maker said its affiliate won 5 million euros ($6.73 million) from the German government to support a three-year research and development project with JV partner Fraunhofer IKTS.

The project aims to improve the company’s power plants’ technology by increasing power density and operating life of fuel cells, leading to lower costs. ($1 = 0.7427 Euros)

** CROWN HOLDINGS INC, $48.56, -5.65 pct

The metal beverage and food can maker’s net income fell to 76 cents per share for the second quarter ended June 30 from 93 cents per share a year earlier.

The company’s cost rose to $1.96 billion from $1.82 billion, while restructuring expenses jumped to $31 million from $4 million.

** HELIX ENERGY SOLUTIONS, $26.06, +6.67 pct

The offshore drilling company’s second-quarter net income more than doubled to 55 cents per share, helped by 100 percent utilization of all three North Sea vessels.

The second quarter was the first full quarter when Helix’s 534 vessel was put to full use.

** CIT GROUP INC, $48.97, +11.42 pct

The U.S. small-business lender said it would buy California bank OneWest Bank NA for $3.4 billion in cash and stock, in a deal that will give CIT a more reliable source of funding.

** INGERSOLL-RAND PLC, $64.28, +3.93 pct

The maker of Trane air conditioners and Thermo King refrigeration units raised its current-year profit forecast as it expects the construction and industrial markets to grow.

** NETFLIX INC, $428.15, -5.27 pct

The video-streaming company planned expansion in Europe will set it up for growth, but increase content and marketing expenses in the near term, analysts said.

** STEEL DYNAMICS INC, $21.8, +5.06 pct

The steelmaker’s second-quarter sales rose 14 percent to $2.1 billion, while profit rose 60 percent.

Cowen and Co and UBS raised their price targets on the company’s stock.

** LOCKHEED MARTIN CORP, $167.06, +2.50 pct

The Pentagon’s largest defense supplier reported a 3.5 percent rise in quarterly profit as higher interest rates lowered its pension liability.


The drugmaker said its experimental cancer drug ganetespib advanced into a late-stage extension trial. The combination of ganetespib and chemotherapy will be studied in elderly patients with acute myeloid leukemia, a type of blood cancer, or high-risk myelodysplastic syndrome, a blood disorder.

** CELGENE CORP, $86.61, +1.52 pct

An anti-cancer drug made by the U.S. biotech firm Celgene can re-activate hidden HIV in patients so that it can be detected, bringing researchers closer to being able to treat it, Danish scientists said on Tuesday.

** YAHOO INC, $33.82, +1.62 pct

Yahoo will buy mobile analytics startup Flurry to beef up a fast-growing mobile advertising business that still lags Google Inc’s and Facebook Inc’s in scale.

Reporting By Shubhankar Chakravorty in Bangalore; Editing by Simon Jennings

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below